COVID-19 Community Levels Map Update, Feb. 3, 2023: The CDC has listed all eight Connecticut Counties in the Medium/Yellow category.  The Connecticut Department of Public Health recommends that all residents consider wearing a mask in public indoor spaces. People who are at high risk for severe illness should consider additional measures to minimize their exposure to COVID-19 and respiratory illnesses. Visit the CDC COVID-19 Community Levels Map for updates.


Please visit covidtests.gov to request four free COVID-19 self-test kits from the Federal Government. Find a location that has a supply of COVID-19 therapeutics as part of the Test to Treat initiative here. The complete DPH COVID-19 toolbox is located at ct.gov/coronavirus.

**New from CTR**

Please visit our Data & Statistics page to view our updated:

 

 Ovarian Cancer Fact Sheet

 

 Interactive Maps  

 

Latest report on Cancer in Connecticut.   

 

 

The Connecticut Tumor Registry (CTR) is a population-based resource for examining cancer patterns in Connecticut. The registry's computerized databases include all reported cancers diagnosed in Connecticut residents from 1935 to the present, as well as follow-up, treatment and survival data on reported cases. All licensed medical providers in Connecticut, as well as all hospitals and private pathology laboratories, are required by law to report cancer cases to the registry.

 

The identities of all patients reported are protected by state confidentiality laws.

 

The registry has been part of the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) program since its inception in 1973. SEER data are reported by 19 geographical areas comprising approximately 34% of the US population, selected for their ability to manage a high quality cancer surveillance system and to provide a representative subset of the nation’s population.

 

 

           

 

 

For more information, please contact CTR at (860) 509-7163.

 

This work has been supported by federal funds from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN261201800002I.